Anixa Biosciences, Inc. Share Price & Technical Analysis
ANIX · $2.79 (+1.45%)
Healthcare / Biotechnology
$2.79
+1.45%
Anixa Biosciences, Inc., a biotechnology company, develops therapies and vaccines that are focused on critical unmet needs in oncology. Its therapeutics programs comprising the development of liraltagene autoleucel, a chimeric endocrine receptor-T cell therapy, a novel form of chimeric antigen receptor-T cell (CAR-T) technology that is focused on treating ovarian cancer. The company also engaged i…
Price chart
Seasonality
May has 1 positive and 4 negative years (last 5 years shown)
-7% return in May, -17% avg return in past 3 year May month.
-8% return in 2026, 0% avg return in past 3 years.
Swipe sideways to see all months →
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Yr | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 26 | -6% | 0% | -10% | 15% | -7% | – | – | – | – | – | – | – | -8% |
| 25 | 21% | 14% | -6% | 0% | -7% | 18% | -6% | -3% | 10% | 24% | 12% | -31% | 45% |
| 24 | 15% | -24% | -11% | -6% | -20% | -8% | 50% | -3% | -3% | 13% | -8% | -30% | -36% |
| 23 | 5% | 0% | -4% | -7% | -24% | 3% | 9% | 3% | -11% | 0% | 3% | 15% | -9% |
| 22 | 10% | -15% | 0% | 14% | 16% | -14% | 27% | 14% | 20% | 12% | -11% | -16% | 56% |
Monthly return % by calendar month · historical pattern, not a forecast
Bearish · Downtrend · Neutral
Anixa Biosciences, Inc., a biotechnology company, develops therapies and vaccines that are focused on critical unmet needs in oncology. Its therapeutics programs comprising the development of liraltagene autoleucel, a chimeric endocrine receptor-T cell therapy, a novel form of chimeric antigen receptor-T cell (CAR-T) technology that is focused on treating ovarian cancer. The company also engaged in the development of a vaccine against breast cancer; and the development of a vaccine discovery program to develop additional cancer vaccines to address intractable cancers, including high incidence malignancies in lung, colon, and prostate. Its vaccine technologies focus on the discovery of additional retired proteins that may be associated with other forms of cancer. The company was formerly known as ITUS Corporation and changed its name to Anixa Biosciences, Inc. in October 2018. Anixa Biosciences, Inc. was incorporated in 1982 and is based in San Jose, California.
Full AI Q&A, portfolio tracking, and live alerts in the app.
Key metrics
Market cap
$96.90M
P/E ratio
—
52W high
$5.46
52W low
$2.44
Volume
40,487
Beta
0.65
Related stocks in Healthcare
Merck & Co Inc Cedear (5…
₹32,900
Abbott Laboratories Cede…
₹30,500
Eli Lilly And Company Ce…
₹25,540
Unitedhealth Group Inc C…
₹17,200
₹6,600
Frequently asked questions
- What is Anixa Biosciences, Inc. share price today?
- Anixa Biosciences, Inc. (ANIX) last traded around $2.79 on StockPro. Prices refresh every few minutes during market hours.
- What technical signals does ANIX have?
- StockPro monitors breakouts, volume spikes, EMA reversals, and momentum for ANIX. Download the app for real-time alerts.
- How can I analyze Anixa Biosciences, Inc. stock?
- Use the price chart, seasonality heatmap, key metrics, and AI insight on this page. For portfolio tracking and push alerts, download StockPro on Android or iOS.